SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 197 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,459,560 | +109.4% | 16,050 | -51.0% | 6.34% | +90.5% |
| Q1 2023 | $4,516,689 | -48.4% | 32,770 | -51.5% | 3.33% | -38.2% |
| Q4 2022 | $8,746,650 | +90.7% | 67,500 | +62.7% | 5.38% | +172.6% |
| Q3 2022 | $4,587,000 | -42.2% | 41,500 | -30.8% | 1.98% | +39.9% |
| Q2 2018 | $7,931,000 | +478.1% | 60,000 | +20.0% | 1.41% | +176.9% |
| Q4 2016 | $1,372,000 | -75.1% | 50,000 | -44.3% | 0.51% | -75.3% |
| Q3 2016 | $5,509,000 | +37.6% | 89,700 | -57.3% | 2.07% | +7.5% |
| Q2 2016 | $4,005,000 | +38.4% | 210,000 | +180.0% | 1.92% | +39.0% |
| Q4 2015 | $2,894,000 | +184.0% | 75,000 | +136.3% | 1.38% | +134.6% |
| Q3 2015 | $1,019,000 | – | 31,744 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |